| HLA-A*24:02 | HLA-A*24:02 | p-value |
---|---|---|---|
matched | unmatched | ||
Number of patients | 36 | 27 | Â |
Age, years | 62.9 ± 2.1 | 63.4 ± 2.1 | 0.7072 |
Gender | Â | Â | 0.3074 |
 Male | 17 (47.2%) | 17 (63.0%) |  |
 Female | 19 (52.8%) | 10 (37.0%) |  |
Stage (UICC) | Â | Â | 0.7439 |
 III | 7 (19.4%) | 5 (18.5%) |  |
 IV | 26 (72.2%) | 21 (77.8%) |  |
 Recurrence | 3 (8.3%) | 1 (3.7%) |  |
Tumor marker | Â | Â | Â |
 CEA | 369.2 ± 247.9 | 8.5 ± 2.1 | 0.1722 |
 CA19-9 | 3870.1 ± 1972.7 | 3643.2 ± 1444.7 | 0.0718 |